Identification of Covid-19 Therapeutics and (Sars-Cov-2) Cluster Cases of India

Authors

  • Azhagu Madhavan S  PG and Research Department of Zoology and Biotechnology, A Veeriya Vandayar Memorial Sri Pushpam College, (An Autonomous Institution Affiliated to Bharathidasan University) Poondi, Thanjavur, Tamil Nadu, India

Keywords:

SARS-CoV-2, COVID-19, 2019-nCoV, ARDS, MERS-CoV

Abstract

The COVID-19 pandemic brought about by the SARSCoV-2 has been a phenomenal worldwide wellbeing challenge. There have been 24,193,010 affirmed instances of COVID-19 around the world influencing 216 nations and 826,141 passings, as of August 27, 2020. In India, there have been 3,310,234 cases with 60,472 passings. Coronavirus, may require genuine thought treatment or even consider, the use of mechanical ventilation for patients with respiratory dissatisfaction. An intense respiratory disorder (ARDS) scene was first recognized in Wuhan, China, and later formally assigned as COVID-19 by the WHO. It is brought about by SARS-CoV-2 that is likely connected with zoonotic transmission. The clinical and hereditary qualities of SARSCoV-2 backing the comparative pathogenesis design between SARS-CoV and MERS-CoV. The raised degree of cytokine discharge during the contamination caused the disappointment of various organs prompting the patient demise. Treatment of patients relies upon the clinical course and indications related with the COVID-19. Human to human transmission through beads, tainted hands just as surfaces, has been uncovered with a brooding period differing from 2-14 days.

References

  1. World Health Organization. Coronavirus disease COVID-19). (2019).pandemic. Available from: https://www.who.int/emergencies/ diseases/novel-coronavirus-, accessed on August 27, 2020.
  2. Ministry of Health and Family Welfare, Government of India. COVID-19 cases in India. (2020) on August 27, Available from: https://www.mohfw. gov.in, accessed.
  3. U.S. National Library of Medicine. ClinicalTrials.gov.(2020). On June 27, Available from: https://clinicaltrials.gov/, accessed
  4. World Health Organization. Draft landscape of COVID-19 candidate vaccines. (2020), on August 27. Available from:https://www.who.int/.publications/m/item/draft-landscape-of-covid-19 candidate vaccines, accessed.
  5. Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. Clinical management protocol: COVID-19. (2020) on June 27, 2020. Available from: https://www.mohfw. gov.in/pdf/ClinicalManagementProtocolforCOVID19.pdf, accessed.
  6. P. Vinotha , Dr. S. Azhagu Madhavan, Ms. V. Uma. (02 - December - 2020). Title of book “Potential Antiviral Effect Of Chloroquine Against Sars-Cov-2 Remdesivir For Different Viruses”. Publisher: Immortal Publications. Eternal World for Research”. ISBN-. (978-93-5426-676-8).
  7. Y. Dong, X.Mo, Y. Hu, X. Qi, F. Jiang, Z. Jiang. (2020). Epidemiology of COVID-19 among children in China. Pediatrics; 145 : e20200702.
  8. U.S. Food & Drug Administration. Exposure-Response Relationships - Study Design, Data Analysis, and Regulatory Applications.(2020) on June 3, Available from: https://www.fda.gov/media/ 71277/download, accessed.
  9. S. Azhagu Madhavan , Senthil J, Ms. V. Uma, Ms. P. Vinotha. (13 - March - 2021). Title Of Book “Energy And Power Covid-19 Research And Development Review”. Black Aviat Publishing House, India. An International Publication Agency based in India. SOCIO-ECONOMIC IMPLICATION OF COVID-19 PANDEMIC. ISBN-. (978-81-946558-0-0).
  10. P. Chatterjee, T. Anand, KJ. Singh, R. Rasaily, R.Singh, S.Das. (2020). Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19. Indian J Med Res; 151 : 459-67.
  11. S. Azhagu Madhavan , Dr. M. Mahadevi, Dr. S. Ganesan . (29- December - 2020). Title of book “Covid -19 Clinical Features”. Publisher: Xpress Publishing. An Important of Notion Press and Amazon. in. Publishing Group. ISBN-10:1637811713. ISBN-13: 978-1-63781-171-9.
  12. M. Majumder,. and K.D.Mandl. (2020). Early Transmissibility Assessment of a Novel Coronavirus in Wuhan, China. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3524675.
  13. R.; Li, W.; Lu, X.; Yang, P.; Feng, O.; Muqimova, , X. Chen and G. Wei,. (2020). Prediction of the Epidemic of COVID-19 Based on Quarantined Surveillance in China. MedRxiv. 2020.02.27.20027169. https://doi.org/10.1101/2020.02.27.20027169.
  14. S. Azhagu Madhavan , Dr. S. Ganesan, Dr. S. Maneemegalai, Dr. P. Vinayaga Moorthi, Dr. M. Mahadevi. (01 - April - 2021). Title of Book “Transmission Qualities And Pathogenesis Of Sars-Cov-2 And Covid-19 Infections In Humans Therapeutics & Recent Developments In Current Evidence Reviews”. HOSPITALITY AND TOURISM INDUSTRY AMID COVID -19 PANDEMIC. Team Hospitality Treasure –Eureka Publications. (A Division of EnTo Tech Pvt. Ltd.) India Office: 604, The Poorva, Pimple Saudagar, Pune, Maharashtra – 411027. First Edition – 2021. ISBN-. (978-81-951936-0-8). [Scopus book chapter publication].
  15. S. Azhagu Madhavan , Vinotha P2, Uma V3 and Mahadevi M4, 2020. Covid-19 Therapeutics & Recent Developments In Current Evidence Reviews. International Research Journal of Modernization in Engineering Technology and Science. Volume: 02/Issue: 09/September -2020. E-ISSN: 2582-5208.
  16. WHO, Coronavirus disease (COVID-19) pandemic, (2020). https://www.who.int/emergencies/diseases/ novel-coronavirus-2019 (accessedAugust1,2020).
  17. J. de Vos, The effect of COVID-19 and subsequent social distancing on travel behavior, Transp. Res. Interdiscip. Per- spect. 5 (2020) 100121, doi: 10.1016/j.trip.2020.100121.
  18. S. Azhagu Madhavan , Dr. S. Ganesan, Ms. P. Vinotha, Ms. V. Uma, Dr. M. Mahadevi, Dr. J. Senthil. (01 - April - 2021). Title of book “Immune System Might Promote Recovery For Mild Covid-19 Patients Impact Of Coronavirus On Education In India Review”. HOSPITALITY AND TOURISM INDUSTRY AMID COVID -19 PANDEMIC. Team Hospitality Treasure –Eureka Publications. (A Division of EnTo Tech Pvt. Ltd.) India Office: 604, The Poorva, Pimple Saudagar, Pune, Maharashtra – 411027. First Edition – 2021. ISBN-. (978-81-951936-0-8). [Scopus book chapter publication].
  19. V. Uma, Dr. S. Azhagu Madhavan , Ms. P. Vinotha. (17 - November - 2020). Title Of Book “Sars-Cov-2 Infection Among Healthcare Workers In India Clinical & Epidemiological Implications”. Publisher: Academia. India & Covid -19: Multi-dimensional Perspective”. (APH PUBLISHING CORPORATION, 4425-36/7, Ansari Road, Darya Ganj, New Delhi. Pin 11002. ISBN-. (978-93-89875-59-1).
  20. J.Zhang, M.Litvinova,Y. Liang Y, Wang, W.Wang, S. Zhao. (2020). Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Science; 368 : 1481-6.
  21. ML, Choudhary, V. Vipat, S. Jadhav, A. Basu, S. Cherian, P. Abraham,. ( 2020). Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India. Indian J Med Res; 151 : 251-4.
  22. S. Azhagu Madhavan , Mahadevi M2, Vinotha P3, Uma V4, and Ganesan S1, From 29-31, January 2021. People Preferences in Selection of Hospital during Covid-19 Impact on Personal Life Review. Online International Conference on Recent Advances in Deep Learning (ICRADL-2021). Organized by the Department of Computer Science and Engineering of Shri Vishnu Engineering College for Women (A), Bhimavaram, AP. (IJERT. Journal). ICRADL - 2021 Conference Proceedings Volume 9, Issue 5, Special Issue - 2021 [ISSN: 2278-0181].
  23. D. Tomasi, (2020). Coronavirus Disease (COVID-19). A Socio-epidemiological Review. Vermont Academy of Arts and Sciences. 1: 1-7.
  24. N.Gupta, S. Agrawal, P.Ish, S.Mishra, R.Gaind, G.Usha. (2020). Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Dis; 10 : 90.
  25. S. Azhagu Madhavan , Ganesan Sa, Mahadevi Mb, Vinotha Pc, Uma Vc, Senthil Jd. 2021. Medical and Healthcare Effective Therapeutic and Covid-19 Role of Herbal Medicine in the Treatment Review. Bulletin of Environment Pharmacology and Life Sciences. (09 March 2021). ISSN: 2277-1808.
  26. National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. (2020) accessed on June 27, Available from: https:// covid19treatmentguidelines.nih.gov/.
  27. SL,. Arnold and F. Buckner. (2020).Hydroxychloroquine for treatment of SARS-CoV-2 Infection? Improving our confidence in a model-based approach to dose selection. Clin Transl Sci; 13 : 642-5.
  28. S. Azhagu Madhavan , Ms. P. Vinotha, Ms. V. Uma. (17 - November - 2020). Title of book “Therapeutic Preferences For Coronavirus (Sars-Cov-2) Patients And Current Evidence On Covid-19”. Publisher: Academia. India & Covid -19: Multi-Dimensional Perspective”. (Aph Publishing Corporation, 4425-36/7, Ansari Road, Darya Ganj, New Delhi. Pin 11002. Isbn-. (978-93-89875-59-1).
  29. C, Smit, MYM, Peeters JN. van den Anker, CA. Knibbe. ( 2020). Chloroquine for SARS-CoV-2: Implications of Its unique pharmacokinetic and safety properties. Clin Pharmacokinet; 59 : 659-69.
  30. S. Azhagu Madhavan , Vinotha P2, Uma V3, Ganesan S4, Senthil J5. 2020. COVID-19 therapeutic and prevention aminoquinolines against coronavirus disease (COVID-19): chloroquine or hydroxychloroquine review. The International Journal of Indian Psychology ISSN 2348-5396 (Online) / ISSN: 2349-3429 (Print) Volume 8, Issue 3, July- Sep, 2020.

International Journal of Scientific Research in Chemistry

Downloads

Published

2021-08-20

Issue

Volume 6, Issue 3, May-June-2021

Section

Research Articles

License

Copyright (c) IJSRCH

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Azhagu Madhavan S, " Identification of Covid-19 Therapeutics and (Sars-Cov-2) Cluster Cases of India, International Journal of Scientific Research in Chemistry(IJSRCH), ISSN : 2456-8457, Volume 6, Issue 3, pp.01-08, May-June-2021.